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Background: In the last decades, the incidence of oesophageal and gastric cardia adenocarcinoma has
increased rapidly in the Western world. We investigated the association between body mass index (BMI),
height and risk of oesophageal and gastric cardia adenocarcinoma.
Methods: The Netherlands Cohort Study was initiated in 1986. All participants (n = 120 852), aged 55–
69 years, completed a self administered questionnaire. Cases were identified through annual record linkage
with the Netherlands Cancer Registry. After 13.3 years of follow-up, excluding the first follow-up year,
complete data from 4552 subcohort members, 133 oesophageal and 163 gastric cardia adenocarcinomas
were available for case-cohort analyses. Incidence rate ratios (RRs) and corresponding 95% confidence
intervals were estimated using Cox proportional hazard models.
Results: The RRs (95% CI) of oesophageal adenocarcinoma were 1.40 (0.95 to 2.04) and 3.96 (2.27 to 6.88)
for overweight (BMI 25.0–29.9 kg/m2) and obese subjects (BMI >30.0 kg/m2), respectively, compared to
subjects with normal weight (BMI 20.0–24.9 kg/m2). For gastric cardia adenocarcinoma, these RRs were
1.32 (0.94 to 1.85) and 2.73 (1.56 to 4.79). Also change in BMI during adulthood was positively associated
with the risk of oesophageal and gastric cardia adenocarcinoma (p trend 0.001 and 0.02, respectively),
while no association was found with BMI in early adulthood (p trend 0.17 and 0.17, respectively). None of
the tumour types investigated was significantly associated with height.
Conclusions: These results confirm higher risks of oesophageal and gastric cardia adenocarcinoma with
increasing BMI. This implies that the increasing prevalence of obesity may be one of the explanations for the
rising incidence of oesophageal and gastric cardia adenocarcinoma in the Western world.
I
n the last decades, the incidence of adenocarcinoma of the
oesophagus and gastric cardia has increased rapidly in the
United States and Western Europe, including the
Netherlands.1–4 In contrast, the incidence of oesophageal
squamous cell carcinoma has been stable, while the incidence
of distal gastric adenocarcinoma has declined.1 3 5 It has been
suggested that the increasing prevalence of obesity in the
Western world6 7 explains these trends in incidence of
adenocarcinoma of the oesophagus and gastric cardia. A
recently published meta-analysis showed a positive association
between body mass index (BMI) and risk of adenocarcinoma of
the oesophagus and possibly of the gastric cardia.8 For
oesophageal squamous cell carcinoma, however, no association
was found with BMI in some studies,5 9 while others found an
increasing BMI to be associated with decreased risk.10–13
Only a few case-control studies studied BMI at age 20 and
found that this factor was positively associated with oesopha-
geal and gastric cardia adenocarcinoma.9 14 15 Some studies also
investigated the association between height and these tumour
types. For oesophageal squamous cell carcinoma and adeno-
carcinoma the results were inconclusive, while no association
was found between height and gastric cardia adenocarci-
noma.5 9 14 16–19
It has been suggested that central obesity leads to a higher
intra-abdominal pressure, which may result in a higher
frequency of gastro-oesophageal reflux.20–24 Frequent reflux of
the gastric acid or bile into the oesophagus may result in a
change of the squamous cell epithelium into a metaplastic
epithelium in the lower third of the oesophagus, a condition
called Barrett’s oesophagus. This condition is thought to be a
premalignant lesion for the development of oesophageal
adenocarcinoma. Several authors, therefore, have suggested
that obesity may increase the risk of oesophageal adenocarcinoma
through a higher frequency of gastro-oesophageal reflux.5 11 25
Whether this mechanism also applies to gastric cardia adenocar-
cinoma is unknown, although a modest but statistically sig-
nificant relation with gastro-oesophageal reflux was found in one
study.24
Most of the studies included in the meta-analysis on BMI
and the risk of adenocarcinoma of the oesophagus and gastric
cardia were case-control studies.8 Such studies are more
vulnerable to information and selection bias, especially hospital
based case-control studies. Only three prospective studies
investigated the association between BMI and the risk of
oesophageal and/or gastric cancer.13 17 18 However, only one of
these studies investigated the risk of both oesophageal and
gastric cardia adenocarcinoma.13 We therefore examined the
association between BMI and the risk of oesophageal and
gastric cardia adenocarcinoma in the Netherlands Cohort Study
on Diet and Cancer. For comparison purposes, we also
investigated the association with BMI for oesophageal squa-
mous cell carcinoma and non-cardia gastric adenocarcinoma.
Because only a few case-control studies investigated BMI in
early adulthood9 14 15 or change in weight during adulthood,5 12
the effects of BMI at age 20 years, change in BMI and height
were also evaluated for all tumours in this prospective study.
MATERIALS AND METHODS
The cohort
In September 1986, the Netherlands Cohort Study on Diet and
Cancer was initiated. The cohort included 58 279 men and
62 573 women who were aged 55–69 years at baseline. Data
processing and analysis were based on a case-cohort design:
Abbreviations: BMI, body mass index; LOS, lower oesophageal sphincter;
NOS, not otherwise specified; RR, rate ratios
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cases were identified from the entire cohort, whereas a random
sample of the cohort (subcohort) was used for estimation of the
accumulated person years in the entire cohort. This subcohort
of 5000 men and women was randomly sampled from the
entire cohort immediately after baseline measurement and is
being followed up biennially for vital status. Subjects in the
cohort with prevalent cancer (other than skin cancer) at
baseline were excluded, leaving 4774 subcohort members (2336
men and 2438 women).
Incident cancer cases occurring in the entire cohort were
identified through annual record linkage to the Netherlands
Cancer Registry and the Netherlands Pathology Registry
(PALGA). The completeness of cancer follow-up was estimated
to be at least 96%.26 Further details on the design of the
Netherlands Cohort Study on Diet and Cancer and the method
of cancer follow-up have been described in previous publica-
tions.27 28
The present analysis is restricted to the 13.3 years of follow-
up period from September 1986 to December 1999. This is the
most recent dataset available for analysis, because cancer
registration, linkage to the cancer registry, checks of the
reported linkages and the processing of the food frequency
questionnaire cause considerable delays.
During this follow-up period, only two subcohort members
were lost to follow-up. After the follow-up period of 13.3 years,
142 incident primary adenocarcinomas (M8140-8141, 8190-
8231, 8260-8263, 8310, 8430, 8480-8490, 8560, 8570-8572)29 of
the oesophagus (ICD-O-3 C15) and 173 incident, primary
adenocarcinomas of the gastric cardia (ICD-O-3 C16.0) were
detected. Also, 108 squamous cell carcinomas (M8050-8076)29
of the oesophagus (ICD-O-3 C15), 280 adenocarcinomas of the
distant stomach (ICD-O-3 C16.1-C16.5) and 208 adenocarci-
nomas of the stomach with an unspecified localisation
(ICD-O-3 C16.6-C16.9) occurred during this follow-up period
(fig 1). All tumours were microscopically confirmed. Among
the group of adenocarcinoma of the stomach with an
unspecified localisation, 12 tumours (5.8%) occurred in the
greater curvature of the stomach (ICD-O-3 C16.6), 130 tumours
(62.5%) had an overlapping sublocalisation within the stomach
(ICD-O-3 C16.8) and in only 66 tumours (31.7%) the exact
location within the stomach (ICD-O-3 C16.9) was unknown.
Baseline questionnaire data
At baseline, all 120 852 cohort members completed a self
administered questionnaire on usual dietary intake and other
risk factors for cancer, such as anthropometry, smoking habits,
physical activity, education and family history of cancer.
Questionnaire data of all cases and subcohort members were
key entered twice and processed in a manner blinded with
respect to case/subcohort status to minimise observer bias in
the coding and interpretation of data. BMI at baseline and BMI
at age 20 years were calculated using weight at baseline and
weight at age 20 years, respectively, divided by height at
baseline squared (kg/m2). BMI at baseline was classified into
the following categories: ,20.0 kg/m2, 20.0–24.9 kg/m2, 25.0–
29.9 kg/m2 and >30.0 kg/m2. Subjects with missing values for
BMI at baseline were excluded from all analyses (fig 1). For
BMI at age 20 years, the categories were ,20.0 kg/m2, 20.0–
21.4 kg/m2, 21.5–22.9 kg/m2, 23.0–24.9 kg/m2 and >25.0 kg/
m2. Change in BMI since age 20 years was calculated as BMI at
baseline minus BMI at age 20 years. This variable was
categorised as ,0 kg/m2, 0–3.9 kg/m2, 4.0–7.9 kg/m2 and
>8.0 kg/m2. Subjects with missing values for BMI at age
20 years were excluded from the analyses of BMI at age
20 years and change in BMI (fig 1).
Table 1 Confounder sets for multivariate analyses with anthropometric variables in the Netherlands Cohort Study on Diet and
Cancer, 1986–1999*
Anthropometrics
Oesophagus Stomach
Squamous cell
carcinoma Adenocarcinoma
Gastric cardia
adenocarcinoma
Adenocarcinoma distant
stomach
Adenocarcinoma stomach,
NOS
BMI at baseline Age Age Age Age Age
Sex Sex Sex Sex Sex
Smoking Smoking Smoking
Education` Education
History of gastric ulcers or
bleeding
BMI at age 20 years Age Age Age Age Age
Sex Sex Sex Sex Sex
Smoking Smoking Smoking
Education Education
History of gastric ulcers or
bleeding
Change in BMI since Age Age Age Age Age
age 20 years Sex Sex Sex Sex Sex
BMI at age 20 years BMI at age 20 years BMI at age 20 years BMI at age 20 years BMI at age 20 years
Smoking Smoking Smoking
Education Education
History of gastric ulcers or
bleeding
Height at baseline Age Age Age Age Age
Sex Sex Sex Sex Sex
BMI at baseline BMI at baseline BMI at baseline BMI at baseline BMI at baseline
Smoking Smoking Smoking Smoking Smoking
Alcohol intake Education Education
Fruit consumption History of gastric ulcers or
bleeding
*NOS, not otherwise specified; BMI, body mass index.
This confounder includes three variables; current smoking (yes/no), number of cigarettes/day and number of years of smoking.
`This confounder refers to the highest level of education (primary school, lower vocational school, high school and higher vocational/university).
1504 Merry, Schouten, Goldbohm, et al
www.gutjnl.com
 on 14 January 2009 gut.bmj.comDownloaded from 
Statistical analysis
In the analyses, the first year of follow-up was omitted, because
the baseline body weight of cases diagnosed in the first year of
follow-up could have been influenced by the presence of
preclinical disease (fig 1).
The mean values of the anthropometric variables were
compared between cases and subcohort members. Other factors
were considered as confounders if they were clearly associated
with the anthropometric variables, if they were associated with
the cancer risk and if rate ratios changed by more than 10%
after adjustment. The confounders considered were age
(continuous), sex, current smoking (yes or no), number of
cigarettes per day (continuous), number of years of smoking
(continuous), alcohol intake (g/day), vegetable and fruit
consumption (g/day), non-occupational physical activity
(,30, 30–59, 60–89 and >90 minutes/day), highest level of
education (primary school, lower vocational, high school and
higher vocational/university), family history of oesophageal
cancer (present or not present in a first degree relative), family
history of stomach cancer (present or not present in a first
degree relative), medical history of chronic intestinal diseases
(yes or no), gastric ulcer or bleeding (yes or no) and reported
use of medications (yes or no) such as antacids (ATC code:
A02A),30 reflux medication (ATC code: A02B),30 or lower
oesophageal sphincter (LOS) relaxing medication (ATC codes:
C01D ‘‘nitroglycerins’’, R03D ‘‘aminophyllines’’, R03A/R03C
‘‘beta receptor agonists’’, A03A/A03C ‘‘anticholinergics’’ and
N05B/N05C ‘‘benzodiazepines’’).30 31 In multivariate analyses
with anthropometric variables, all rate ratios (RRs) of every
tumour type in this study were adjusted for age and sex. The
analyses of change in BMI were also further adjusted for BMI at
age 20 years, while the analyses of height were further adjusted
for BMI at baseline. In addition, a different set of confounders
was defined for every tumour type in this study (table 1). Cases
and subcohort members with missing data on confounders
were excluded from the analyses (fig 1).
Incidence RRs and corresponding 95% confidence intervals
(95% CI) were estimated in Cox proportional hazards models
using the Stata statistical software package (Stata Corporation,
College Station, TX, USA), after testing of the proportional
hazards assumption using the scaled Schoenfeld residuals.32
Standard errors were estimated using the robust Hubert-White
sandwich estimator to account for additional variance intro-
duced by sampling from the cohort.33 To obtain p values for
dose-response trends, ordinal exposure variables were fitted as
continuous terms in the regression models. Two sided p values
are reported throughout this paper.
RESULTS
BMI at baseline was higher among cases with adenocarcinoma
of the oesophagus and gastric cardia compared to subcohort
members, while cases with oesophageal squamous cell carci-
noma had a lower BMI at baseline (table 2). At age 20 years,
especially, female cases with squamous cell carcinoma and
adenocarcinoma of the oesophagus had a higher BMI compared
to female subcohort members (mean values, 22.1 kg/m2 and
22.6 kg/m2 versus 21.4 kg/m2, respectively). For men, however,
no great differences were observed for BMI at age 20 years
between the cases and the subcohort, except for a higher BMI
at age 20 years among cases with adenocarcinoma of the gastric
cardia.
Table 2 also shows the distribution of the confounding
factors among cases and subcohort members. A higher number
of current smokers at baseline were found among cases with
oesophageal squamous cell carcinoma compared to the other
cases and subcohort members. In addition, these cases also
consumed more alcohol than the other cases and subcohort
members. Especially among women, there were more alcohol
consumers among cases with oesophageal squamous cell
carcinoma than in the other groups.
The multivariate adjusted RRs for the three BMI variables are
shown in table 3. For both oesophageal and gastric cardia
Figure 1 Flow diagram of numbers of subcohort members and cases on whom the analyses were based. *Abbreviations: NCR, Netherlands Cancer
Registry; PALGA, Netherlands Pathology Register; SC, squamous cell carcinoma; AC, adenocarcinoma; NOS, not otherwise specified; BMI, body mass
index. Range of subcohort members. Numbers of subcohort members in the analyses were dependent on the different confounder sets for every tumour
type in this study.
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adenocarcinoma, a clearly positive dose-response trend was
seen with BMI at baseline (p for trend 0.001 and 0.002,
respectively). However, for oesophageal squamous cell carci-
noma a negative trend was found with increasing BMI at
baseline (p for trend 0.04). No significant associations were
found between BMI at baseline and the risk of non-cardia
gastric adenocarcinoma. Underweight (BMI ,20.0 kg/m2) was
associated with a nearly statistically significant increased risk of
squamous cell carcinoma (RR = 2.21; 95% CI 0.99 to 4.92).
The BMI differences between the cases and the subcohort
were more prominent in women than in men, while the cases
are mostly men (table 2). However, when the analyses were
restricted to men, we still found a strong positive association
between BMI at baseline and the risk of oesophageal and
gastric cardia adenocarcinoma (p for trend 0.005 and 0.004,
respectively).
BMI at 20 years of age was associated with the risk of
adenocarcinoma of the gastric cardia (per 1 kg/m2 increment,
RR = 1.07; 95% CI 1.00 to 1.15) although the p for trend in
categorical analysis was not significant (p = 0.17).
Furthermore, subjects who were overweight (BMI (>25.0 kg/
m2) at 20 years of age had a significantly higher risk of
oesophageal squamous cell carcinoma (RR = 2.49; 95% CI 1.15
to 5.40). No significant associations were found between BMI
at 20 years of age and the risk of the other tumour types. A gain
in BMI of 1 kg/m2 increment after 20 years of age increased the
risk of adenocarcinoma of the oesophagus to 14%. Subjects
with a BMI gain of >8.0 kg/m2 had a 3.4 times higher risk of
oesophageal adenocarcinoma compared to subjects with 0–
3.9 kg/m2 change in BMI (table 3). Also for gastric cardia
adenocarcinoma a significant positive trend was found with a
gain in BMI (p for trend = 0.02). No associations were found
between change in BMI and the other three tumour types.
Subjects with weight loss had a significantly higher risk of
oesophageal squamous cell carcinoma compared to subjects
with a BMI change 0–3.9 kg/m2 (RR = 2.57; 95% CI 1.40 to
4.72).
In table 4, the multivariate adjusted RRs for height at
baseline are shown. Inverse associations with height were
found for oesophageal squamous cell carcinoma and adeno-
carcinoma of the distant stomach although these associations
were not statistically significant (p for trend = 0.22 and 0.07,
respectively). A positive, non-statistically significant, trend with
increasing height, was found for gastric cardia adenocarcinoma
(p for trend = 0.06).
DISCUSSION
Our results confirm that BMI at baseline is a strong risk factor
for adenocarcinoma of the oesophagus and gastric cardia. Also
change in BMI during adulthood increased the risks of these
tumours, while BMI at 20 years of age was only positively
associated with the risk of gastric cardia adenocarcinoma.
Furthermore, subjects in the lowest classes of the BMI at
baseline (,20.0 kg/m2) had a higher risk of oesophageal
squamous cell carcinoma, although this association was not
statistically significant. A significantly higher risk of this
tumour was found with weight loss after age 20 years. For
height, no statistically significant associations were found with
any of the tumour types investigated.
It is unlikely that the results in this prospective cohort study
have been affected by selection or information bias. During the
13.3 years of follow-up, only two subcohort members (0.04%)
were lost to follow-up. It was estimated that coverage of the
cancer follow-up of the entire cohort was at least 96%.26
Therefore, exposure related loss to follow-up is unlikely.
If the presence of preclinical disease has influenced the
weight of the cases, this may lead to a higher risk of cancer with
lower BMI (reverse causation), especially when this association
would be found for weight loss during adulthood. For this
reason, we excluded cases diagnosed in the first year of follow-
up. However, it is not clear whether this is sufficient.
In additional analyses in which we excluded none, one, two
and five follow-up years, we found no differences in the
strength of the association between BMI at baseline and either
of the five tumour types investigated. So, the strong positive
association between BMI at baseline and the risk of oesopha-
geal and gastric adenocarcinoma was not dependent on the
number of follow-up years excluded.
Since the data on the anthropometry in this study are self
reported, misclassification of exposure is a potential source of
bias. Some studies have found that self reported and measured
weight and height were strongly correlated.34 35 Other studies
also found that men are more inclined to over-report their
height, while women are more inclined to under-report their
weight.34 36 These misclassifications, however, lead to lower
estimates of the BMI and probably to an underestimate of the
effect of BMI on the risk of the tumour types in this study.
BMI at 20 years of age was calculated using the self reported
weight at age 20 years. Because it is difficult to remember the
weight at age 20 years, some recall bias may have occurred for
this variable. However, this recall bias is expected to be non-
differential.
Another potential source of bias is misclassification of
tumours. It is unlikely, however, that this misclassification
has attenuated our results. Firstly, there is a clear difference in
the relative risks of squamous cell carcinoma and adenocarci-
noma of the oesophagus and of adenocarcinoma of gastric
cardia and other parts of the stomach. Secondly, the association
with BMI is very strong for both oesophageal and gastric cardia
adenocarcinoma. In addition, the associations of these tumours
with BMI are very similar. So, misclassification of these
tumours had to be very large to lead to these results.
Therefore, it is unlikely that the associations found in this
study are attenuated by tumour misclassification.
A recently published meta-analysis found a dose dependent
association between a higher BMI and the risk of adenocarci-
noma of the oesophagus and possibly of the gastric cardia.8 Of
the three prospective studies in this meta-analysis, two studies
also found higher risks of adenocarcinoma of the oesophagus
and/or gastric cardia with BMI,13 17 while the third study found
no association between BMI and gastric cardia adenocarci-
noma.18 However, the study of Tran et al18 was based on a
Chinese population who on average is leaner than Western
populations and, therefore, has a different distribution of the
BMI. Furthermore, two of the studies in this meta-analysis
found an inverse trend between an increasing BMI and the risk
of oesophageal squamous cell carcinoma,13 18 as was also found
in our study.
Only three case-control studies have investigated the effects
of BMI at 20 years of age.9 14 15 All three found significant
higher risks for oesophageal and/or gastric cardia adenocarci-
noma with increasing BMI at 20 years of age. Lagergren et al9
also found a statistically significant higher risk of oesophageal
squamous cell carcinoma, while Wu et al14 found a significant
positive trend with increasing BMI at 20 years of age for
adenocarcinoma of the distant stomach. In our study, how-
ever, no significant risk estimates were found with BMI at
20 years of age, except for gastric cardia adenocarcinoma.
Furthermore, we found that the associations for BMI at
20 years of age were less obvious compared to BMI at baseline.
Wu et al also found a stronger association between the current
BMI and oesophageal adenocarcinoma, while for gastric cardia
adenocarcinoma, the association with BMI at 20 years of age
was stronger.14
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In our study, higher risks of oesophageal and gastric cardia
adenocarcinoma were found with gain in BMI during adult-
hood compared to 0–3.9 kg/m2 change in BMI. Chow et al also
found a significantly higher risk of oesophageal adenocarci-
noma for subjects with a weight change>20.87 kg compared to
subjects with 0–2.27 kg change in weight (OR = 2.1; 95% CI
1.2 to 3.8), while they found no association with gastric cardia
adenocarcinoma.5
A possible explanation for this strong association between
BMI and risk of adenocarcinoma of the oesophagus and gastric
cardia is the effect of high BMI on gastro-oesophageal reflux. A
higher BMI is thought to increase the intra-abdominal pressure
that can lead to a higher frequency of this reflux.20–24 Chronic
reflux may damage the oesophageal squamous cell epithelium
that can change in a metaplastic epithelium, a condition called
Barrett’s oesophagus. This condition is thought to be a
premalignant lesion for adenocarcinoma of the oesophagus.
Furthermore, we found that change in BMI during adulthood
was positively related to adenocarcinoma of the oesophagus,
while no association was found with BMI at age 20 years. It is
unknown as yet whether a high BMI itself or especially an
increase in BMI during adulthood will lead to a higher
frequency of gastro-oesophageal reflux. One study found that
even a moderate gain in weight among people of normal weight
may cause or exacerbate symptoms of reflux which may
increase the risk of this tumour.37 Further research is needed
on the association between change in weight during adulthood
and the frequency and severity of gastro-oesophageal reflux.
It is yet unclear what the exact role of this mechanism is for
adenocarcinoma of the gastric cardia, although a modest but
significant association with gastro-oesophageal reflux symp-
toms and the risk of this tumour was found in one study.24
In this study, it was not possible to evaluate this mechanism
by reflux on the risk of oesophageal and gastric cardia
adenocarcinoma, because we did not have information on the
frequency or severity of reflux symptoms of the participants.
This information possibly could be obtained from the data on
the use of reflux medications. However, because the use of
these medications is self reported and participants were asked
to report only medications that were used for more than six
months, it is likely that this information is incomplete. In
additional analyses, in which the use of antacids, reflux and
LOS relaxing medication were added as extra confounders, we
found no changes in the association between BMI at baseline
and the risk of oesophageal and gastric cardia adenocarcinoma,
which can be explained by the low reported prevalence of the
use of these medications in our study population.
In this study, no association was found between height and
adenocarcinoma of the oesophagus, which was also found in
the Norwegian cohort study.17 In contrast, one case-control
study found height to be a risk factor for this tumour,14 while
two others found a lower risk of oesophageal adenocarcinoma
with increasing height.5 9 Furthermore, the Norwegian study
found a protective effect of height on oesophageal squamous
cell carcinoma.17 This trend was also seen in our study,
although it was not significant. The Chinese cohort study,
however, found height to be a risk factor for this tumour.18 But
a Chinese population is on average shorter than Western
populations, which may explain these differences in results.
This study confirms a strong dose dependent association
between BMI and the risk of adenocarcinoma of the oesopha-
gus and gastric cardia. No associations were found with BMI at
age 20 years, while change in BMI during adulthood was found
to be a strong risk factor, especially for oesophageal adeno-
carcinoma. In this relatively lean population, 30.2% of
oesophageal adenocarcinoma and 21.8% of gastric cardia
adenocarcinoma could be attributed to overweight or obesity.
Since the conception of the cohort, obesity has become more
prevalent in most Western societies, including the Netherlands
and it is likely that the increasing prevalence of overweight and
obesity has contributed to the rising incidence of adenocarci-
noma of the oesophagus and gastric cardia.
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Robin Spiller, editor
Haemorrhagic gastritis in a neurologically impaired boy
Clinical presentation
A 7-year-old boy, affected by spastic quadriplegia secondary to
perinatal respiratory distress, presented with a 15-day history of
severe abdominal pain. Paracetamol and omeprazole brought
no relief. On physical examination, the boy was in a poor
general state, but with normal vital signs, and with a flat and
soft abdomen without tenderness. There was no organomegaly.
However, diffuse hyperkeratosis, joint pain and petechial
haemorrhages on the legs, together with swollen and friable
gums were present. He had no history of trauma, fever or
weight loss. Initial blood tests for haemachrome, electrolytes,
coagulation factors, liver and muscle enzymes, renal function,
rheumatoid factors and infectious agents were all normal. The
erythrocyte sedimentation rate was 40 mm/h and C-reactive
protein was 5.87 mg/dl (reference range,0.50). Cardiac func-
tion and abdominal ultrasound evaluation were unremarkable.
Upper endoscopy showed a haemorrhagic aspect of the antrum
with diffuse petechiae, very similar to that observed at the
cutaneous level (fig 1) without any evidence of Helicobacter pylori
infection.
Question
What is the diagnosis?
See page 1535 for answer
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Figure 1 Endoscopic view of the antrum.
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